The gene coding for the filamentous hemagglutinin (FHA), one of the main factors involved in mediating adherence of Bordetella pertussis to ciliated host cells, was cloned in Escherichia coli, and the 3,500-base-pair nucleotide sequence encoding the amino-terminal region was determined. Molecular cloning, together with the characterization of recombinant FHA-related proteins produced in E. coli, revealed that the primary translation product is a protein of about 370 kilodaltons (kDa). The mature 220-kDa FHA polypeptide secreted by B. pertussis is most probably generated by proteolytic processing that eliminates a carboxy-terminal portion of about 150 kDa. The 1,087 amino-terminal residues of the predicted FHA sequence showed a number of remarkable features. Extensive homology to the Serratia marcescens and Proteus mirabilis hemolysin proteins was found between amino acids 91 and 205 of the FHA sequence, suggesting involvement of this FHA domain in host cell binding or secretion of FHA from B. pertussis. In addition, two regions containing repetitive amino acid sequences were identified. One region, extending from residues 382 to 664, was formed by six repeats, and a second, extending from residues 701 to 912, contained three repeats. The reactivities of several recombinant FHA-derived proteins with a panel of monoclonal antibodies identified at least four epitopes composing an immunoreactive domain present in the carboxy-terminal moiety of the mature FHA.
Virulent Bordetella pertussis, the etiologic agent of whooping cough, is characterized by the coordinated synthesis of a variety of virulence factors (37) . These include toxins and adherence factors such as pertussis toxin (PTX), extracellular adenylate cyclase, dermonecrotic toxin, filamentous hemagglutinin (FHA), and agglutinogens. Some of these factors are known to be important protective antigens in pertussis vaccines, and the major antigens included in the new acellular vaccines are PTX and FHA (12, 29) . The amino acid sequence of PTX has been deduced from the cloning (16, 22) and sequencing (18, 22) of its structural gene. Individual subunits of PTX have been synthesized in heterologous hosts and analyzed for biochemical activity and immunological properties (1, 3, 17, 21, 26) . Much less is known about the properties of FHA. Cloning and expression in Escherichia coli of the partial structural gene have been reported (2, 11, 20, 25) . The important immunogenic regions on the FHA molecule have not yet been identified, despite the fact that immunization with FHA protects mice from aerosol challenge with virulent B. pertussis (23, 28) . Furthermore, FHA has the ability to adhere to human ciliated respiratory epithelial cells (33) and probably plays an important role in the attachment of B. pertussis to the respiratory tract, one of the initial steps in the pathogenesis of whooping cough. Characterization of the epithelial cell-binding sites on FHA and identification of neutralizing epitopes are therefore important steps toward the definition of an FHA molecule useful for vaccine purposes. An understanding of the mechanisms intervening in the expression and posttranslational 2896 DELISSE-GATHOYE ET AL. agar plates (Difco Laboratories, Detroit, Mich.) or liquid Stainer-Scholte medium (32) . E. coli cells were grown in Luria broth (LB) supplemented with ampicillin (200 ,uglml) when necessary (19, 27 (19, 27) . DNA sequencing. Restriction fragments of recombinant plasmids containing the FHA structural gene were subcloned into different pUC plasmids. The DNA inserts were sequenced by the dideoxy-chain termination method adapted for plasmids (4), using Sequenase (United States Biochemical Corp., Cleveland, Ohio). To sequence through regions with DNA compression, dITP was used in all four sequencing reaction mixes (27) .
Polyclonal antisera. The polyclonal antisera used were kindly provided by E. Simoen (Smith Kline Biologicals, Rixensart, Belgium). Anti-FHA polyclonal antiserum was obtained by immunization of a goat with FHA purified by standard techniques (11) . Anti-Bordetella polyclonal antiserum was obtained by immunization of guinea pigs with heat-killed whole bacteria of B. pertussis Tohama I.
Generation of monoclonal anti-FHA antibodies. BALB/c mice were immunized intraperitoneally with one-third of a human dose of whole-cell pertussis vaccine and boosted intraperitoneally 3 weeks later with 500 jig of purified FHA adsorbed to AI(OH)3. The fusion procedure was essentially as described by Kohler and Milstein (14) (38) . To generate probe A, B. pertussis BP353 DNA was digested with Sall restriction enzyme and inserted into pUC9 previously digested with SalI. E. coli MM294 was transformed to ampicillin resistance with the recombinant plasmids and then screened by using the radiolabeled neomycin resistance gene carried by TnS. Two clones both containing about 350 base pairs (bp) of B. pertussis DNA adjacent to the TnS insertion were isolated. A 550-bp Sall-HpaI DNA fragment including the 350 bp of B. pertussis DNA was then purified, radiolabeled, and used as probe A. Probes Bi and B2 were synthetic oligonucleotides with the sequences CACATGC ACCTGGATGCGCCGCGC and GGACCAGCCTGGCCCG AGCGCTGC, corresponding to extremities I and II, respectively, of the 2.9-kilobase-pair (kb) recombinant B. pertussis DNA insert described by Mattei et al (20) . Probe C was generated by reverse translation of a portion of the FHA protein sequence. This probe was a 32-residue-long synthetic oligonucleotide with the sequence CAGGACTTCTTC ACCCCGGGCAGCGTCGTCGT (11) . The codon usage was chosen according to the sequence of the PTX gene (18) . Several clones hybridizing to one or two of the probes described above were isolated from the B. pertussis gene library. Probe B2 hybridized to many clones in the gene library but did not hybridize to clones that simultaneously hybridized to any of the other probes. Therefore, probe B2 probably hybridized to DNA that is not part of the FHA gene, as discussed by Mattei et al. (20) . Four of the isolated clones together cover a chromosomal region of about 20 kb. A restriction map of each cloned DNA insert was obtained, and the regions hybridizing to the individual DNA probes were identified ( Fig. la to d) . The BamHIa-XhoIa (superscripts indicate restriction sites) fragment that hybridized to probe C was subcloned and sequenced. One of the three possible reading frames was in perfect correspondence to the determined protein sequence (11) . However, neither an ATG initiation codon nor a sequence coding for a putative signal peptide (6) could be found in the region immediately upstream of the sequence corresponding to probe C. Instead, a potential cleavage site for trypsinlike proteases (Arg-ArgAla-Arg-Arg) was found at position 1074 of the sequence shown in Fig. 2 . When the 800-bp BamHIa-XhoIa (Fig. le,  fragment 6 ) DNA fragment was subcloned into pUC8 such that the putative FHA-coding sequence was in frame with the first nine amino acids of the P-galactosidase open reading frame (ORF), a fusion protein was synthesized in E. coli that could be detected with anti-FHA polyclonal antiserum (11) . This finding strongly indicated that the 20-kb DNA, covered by the four clones, encodes the structural gene of FHA.
Identification of the 5' end of the FHA structural gene.
Since the DNA sequence analysis discussed above suggested that the 800-bp BamHIa-XhoIa fragment codes for an internal FHA fragment rather than the amino-terminal region, the upstream region was sequenced up to the EcoRIa site of pRIT13075 (Fig. ld) . The sequence revealed one ORF starting 253 bp downstream of this EcoRI site (Fig. 2) and extending through the sequenced region. Three in-frame ATG codons were found as possible candidates for the initiation of translation. An amino acid sequence with some features of a signal peptide was found between residues 33 to Because of the high C+G content of B. pertussis DNA, unambiguous sequence data are difficult to obtain and misinterpretation of the reading frame through sequence errors is difficult to avoid. An expression strategy was therefore developed to verify that the correct ORF had been identified. Several fragments of the 5' region of the FHA gene were inserted in all three reading frames into the universal pUC vectors (9) , and the expression products were analyzed with anti-FHA polyclonal antiserum. Six adjacent or overlapping fragments covering together almost 3,000 bp of the 5' region were analyzed (fragments 1 to 6; Fig. le Fig. 1 and 5 ) and the putative promoter sequence are underlined. ments 2, 3, 8, and 9 were expressed in the absence as well as in the presence of IPTG. In contrast, the expression of fragments 6 and 7, although observed in the absence of IPTG, was enhanced in the presence of IPTG, indicating that their expression is under the control of the lac promoter.
To more precisely locate the translational stop codon, expression of overlapping and contiguous B. pertussis sequences was carried out in E. coli (fragments 8 to 12; Fig.  le ). E. coli transformed with the recombinant plasmids pRIT13197, pRIT13202, pRIT13210, pRIT13296, and pRIT 13338 ( Table 1) produced proteins of 175, 270, 145, 190, and 190 kDa, respectively, that were immunodetected with polyclonal anti-FHA antiserum (Fig. 3) . Among the different recombinant proteins, the protein encoded by fragment 12 showed an Mr of 190,000, identical to that encoded by fragment 11. For all recombinant clones except the one containing fragment 12, the size of the anti-FHA-reactive polypeptide corresponded well to the size of the DNA insert. These results indicated that the translational stop codon for the FHA ORF is located in the vicinity of the ClaIa site. Taken together, the results of DNA sequencing and expression allowed us to conclude that the structural gene coding 
on November 6, 2017 by guest http://iai.asm.org/ Downloaded from 2900 DELISSE-GATHOYE ET AL. 13335, pRIT13336, pRIT13337, pRIT13272, pRIT13274, and pRIT13276; Table 1) revealed that they did not react with the anti-FHA polyclonal or monoclonal antibodies, nor did they react with polyclonal antiserum raised against whole B. pertussis organisms. This lack of reaction cannot be attributed to the lack of expression, since in one case (pRIT13276) one of the frames resulted in the production of a polypeptide clearly identifiable by Coomassie blue staining after SDS-PAGE. Synthesis of this polypeptide was inducible by IPTG (not shown). Moreover, the observed Mr of the produced polypeptide corresponded well with the Mr calculated from the size of the inserted DNA. These data suggest that DNA fragments 13 and 14 in Fig. le To analyze the probable processing steps leading to mature FHA, various recombinant FHA-related proteins, as well as purified FHA, were analyzed by Western blot, using monoclonal anti-FHA antibodies. The five recombinant proteins used correspond to fragments 3, 6, 7, 10, and 11 (Fig.  le) . The results of this Western blot analysis except for fragment 6 are shown in Fig. 4 . All of the monoclonal antibodies recognized fragment 7, suggesting that this fragment constitutes a highly immunogenic portion of the FHA molecule, at least in mice. By using the recombinant proteins as antigens, the monoclonal antibodies can be subdivided into two groups: those reacting with fragment 7 but not with fragments 3, 6, 10, and 11, and those reacting with fragments 7, 10, and 11 but not with fragments 3 and 6. Therefore, the epitopes for all of these monoclonal antibodies are located in the portion of the FHA molecule that is encoded by the XhoIa_PStIb DNA fragment depicted in Fig. le. FHA purified from the B. pertussis culture medium is usually composed of a major 220-kDa polypeptide and three minor (140-, 130-, and 90-kDa) polypeptides that can be resolved by SDS-PAGE (11 protein, and to align the antigenic structure of FHA with its structural gene (Fig. 5 ).
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The portion encoded by the XhoIajPStIb DNA fragment is highly immunogenic and contains at least four distinct epitopes immunodominant in mice. The portion of FHA encoded by the EcoRIa-XhoIa DNA fragment was not recognized by the monoclonal antibodies used here but was recognized by polyclonal anti-FHA antibodies. Finally, the carboxy-terminal portion of the FHA appears not to react with antibodies produced in rabbits, mice, or guinea pigs.
DISCUSSION
The B. pertussis FHA molecule is a likely component of the new generation vaccines against whooping cough (12, 29) . To characterize this antigen at the molecular level, its structural gene was cloned in E. coli. By using three different DNA probes, four DNA fragments covering the entire structural gene were isolated. The 5' portion of the gene was sequenced up to the region that hybridized to probe C. This sequence is identical to the one reported by Relman et codons were found in all three reading frames upstream of the first ATG codon. None of the ATG codons were preceded by sequences homologous to the Shine-Dalgarno ribosome-binding sequences. Analysis by the statistical TESTCODE algorithm (7) to differentiate between true proteincoding sequences and fortuitous ORFs indicated that the ORF starting with the first of the three ATG codons has a high coding probability. This finding is in agreement with those of Relman et al. (25) . A promoterlike structure was identified that contained the sequences TTGACTA and TATAAAT at positions 83 and 111, respectively, downstream of the first EcoRI site. The distance between these two sequences, which have homology to other bacterial promoter elements, is 21 nucleotides. This distance is significantly greater than that found in efficient E. coli promoters; however, the same distance was found in other B. pertussis promoters such as the PTX promoter (18) . A sequence resembling somewhat a procaryotic signal peptide can be found in the near amino terminus of the proposed protein sequence, with a positively charged region from amino acids 33 to 43, a hydrophobic stretch from 49 to 68, and the (-3, -1) rule followed in the triplet at 69 to 71 (36) . The hydrophobic region between residues 52 and 69 has previously been noticed by Relman et al. (25) . The cleavage site of this unusually long signal peptide would then be located after Ala-71. A shorter signal peptide, but still longer than usual, could result from initiating the translation at the second Met residue. Unsuccessful attempts were made to sequence the amino terminus of the mature FHA protein, which seems to be blocked. It cannot be decided at this time whether the sequence features mentioned above characterize a true signal peptide or an uncleaved one, which would then act as an anchor of the antigen into the membrane. The aminoterminal portion of the FHA protein shows striking homology to the amino-terminal region of the hemolysins A of S. marcescens (24) and P. mirabilis (34) . The homology to the P. mirabilis hemolysin is particularly interesting since, unlike S. marcescens, P. mirabilis is very different in C+G content (38%) from B. pertussis (67%). Therefore, the ho- Table 2 . Lanes: a, purified FHA; b to e, E. coli extracts with recombinant FHA polypeptides encoded by DNA fragments 3, 7, 10, and 11, respectively; f, extract from E. coli with the pUC vector. Numbers in the margins represent Mr standards (in thousands [K] ). mology at the amino acid sequence level can be considered highly significant. The sequence starting from amino acid residue 53 of the S. marcescens hemolysin and extending to residue 168 shows 48% identity with the B. pertussis FHA sequence, and most amino acid substitutions are conservative changes. The P. mirabilis hemolysin shares 47% identity with the same FHA region. The two hemolysins share 72% identity in that region ( Fig. 6a; Fig. 2, box I) .
Schiebel et al. (31) have recently shown that the secretion and activation mechanism of ShlA is dependent on the presence of the shlB gene product. In addition, ShiB-mediated secretion and activation of ShlA require the 261 aminoterminal residues of ShlA, indicating that the information for export to the cell surface and secretion into the culture medium is located in the amino-terminal domain of the protein. The high degree of homology of this region with the Fig. 1 is required for binding of the FHA molecule. In addition, they found an RGD sequence and suggested that existence of an RGD-dependent fibronectinlike binding for FHA to integrinrelated molecules. Using the recombinant protein encoded by DNA fragment 7 (Fig. le) , we were unable to detect any hemagglutinating activity. Furthermore, the recombinant protein was also unable to inhibit FHA-mediated hemagglutination (data not shown). These findings suggest that although the RGD region of the FHA protein may be required for FHA activity on some cells (e.g., leukocytes), it is not sufficient. Alternatively, FHA may have developed more than one mechanism of binding, and different mechanisms may be used on different target cells. It is therefore tempting (24) , and the sequence of the P. mirabilis hemolysin (Hpma) was reported by Uphoff and Welch (34 amino acid residues per repeat unit. The first region of repeats extends from residues 382 to 664 and contains six repeat units ( Fig. 6b; Fig. 2 , box II). The second region extends from residues 701 to 912 and contains three repeat units ( Fig. 6c; Fig. 2 Comparison of the DNA-derived protein sequence and the partial sequence published previously (11) indicated that trypsinlike proteolytic cleavage occurs after the RRARR sequence at amino acid position 1073 also noted by Relman et al. (25) . Therefore, the smaller peptides in the purified FHA fraction are likely proteolytic cleavage products of the larger 220-kDa polypeptide. It has been previously reported that depending on storage conditions, the purified FHA appears to be composed by polypeptides with molecular masses ranging from 60 to 220 kDa. The different polypeptides species shared antigenic determinants when analyzed by specific anti-FHA monoclonal antibodies (10) . Epitope mapping of the recombinant proteins and the polypeptides from purified B. pertussis FHA confirmed this finding and further suggested that the 90-kDa polypeptide represents the middle portion of the immature FHA molecule. Other FHA polypeptides (130 and 140 kDa) were also recognized by some of the monoclonal antibodies, indicating that they are also internal fragments of the FHA.
It is striking that all of the monoclonal antibodies reacted with the recombinant protein encoded by DNA fragment 7, the middle region of the FHA structural gene, suggesting that this region may be an important immunodominant domain of FHA. At least four different epitopes could be identified in this domain. Since the same region seems to be required for adherence to ciliated cells, the antibodies against it may be important in the prevention of binding of FHA to ciliated cells, and their putative role as antiadherence antibodies in the immune response against B. pertussis infection or by vaccination should be investigated. The monoclonal antibodies are now being used in mouse protective models as well as for cell-binding inhibition studies in vitro. We are also now investigating the potential of the recombinant proteins encoded by the different DNA fragments described in Fig. le in eliciting protective immunity to B. pertussis infection.
